Original Article

Trans unsaturated fatty acids inhibit lecithin: cholesterol acyltransferase and alter its positional specificity

Correspondence to: Papasani V. Subbaiah.

Although dietary trans unsaturated fatty acids (TUFA) are known to decrease plasma HDL, the underlying mechanisms for this effect are unclear. We tested the hypothesis that the decreased HDL is due to an inhibition of lecithin:cholesterol acyltransferase (LCAT), the enzyme essential for the formation of HDL, by determining the activity of purified LCAT in the presence of synthetic phosphatidylcholine (PC) substrates containing TUFA. Both human and rat LCATs exhibited significantly lower activity (-37% to -50%) with PCs containing 18:1t or 18:2t, when compared with the PCs containing corresponding cis isomers. TUFA-containing PCs also inhibited the enzyme activity competitively, when added to egg PC substrate. The inhibition of LCAT activity was not due to changes in the fluidity of the substrate particle. However, the inhibition depended on the position occupied by TUFA in the PC, as well as on the paired fatty acid. Thus, for human LCAT, 18:1t was more inhibitory when present at sn -2 position of PC, than at sn -1, when paired with 16:0. In contrast, when paired with 20:4, 18:1t was more inhibitory at sn -1 position of PC. Both human and rat LCATs, which are normally specific for the sn -2 acyl group of PC, exhibited an alteration in their positional specificity when 16:0–18:1t PC or 16:1t –20:4 PC was used as substrate, deriving 26 – 86% of the total acyl groups for cholesterol esterification from the sn -1 position.

These results show that the trans fatty acids decrease high density lipoprotein through their inhibition of lecithin: cholesterol acyltransferase (LCAT) activity, and also alter LCAT's positional specificity, inducing the formation of more saturated cholesteryl esters, which are more atherogenic.—Subbaiah, P. V., V. S. Subramanian, and M. Liu. Trans unsaturated fatty acids inhibit lecithin:cholesterol acyltransferase and alter its positional specificity. J. Lipid Res. 1998. 39: 1438–1447.

Supplementary key words: high density lipoproteins, LCAT, cholesterol esterification, fluidity, acyl chain length

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. V. Subbaiah, J. M. Sowa, and M. H. Davidson Evidence for altered positional specificity of LCAT in vivo: studies with docosahexaenoic acid feeding in humans J. Lipid Res., December 1, 2004; 45(12): 2245 - 2251. [Abstract] [Full Text] [PDF]

				N. R. Matthan, F. K. Welty, P. H. R. Barrett, C. Harausz, G. G. Dolnikowski, J. S. Parks, R. H. Eckel, E. J. Schaefer, and A. H. Lichtenstein Dietary Hydrogenated Fat Increases High-Density Lipoprotein apoA-I Catabolism and Decreases Low-Density Lipoprotein apoB-100 Catabolism in Hypercholesterolemic Women Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1092 - 1097. [Abstract] [Full Text]

				A. H. Lichtenstein, M. Jauhiainen, S. McGladdery, L. M. Ausman, S. M. Jalbert, M. Vilella-Bach, C. Ehnholm, J. Frohlich, and E. J. Schaefer Impact of hydrogenated fat on high density lipoprotein subfractions and metabolism J. Lipid Res., April 1, 2001; 42(4): 597 - 604. [Abstract] [Full Text]

				F. A Kummerow, Q. Zhou, and M. M Mahfouz Effect of trans fatty acids on calcium influx into human arterial endothelial cells Am. J. Clinical Nutrition, November 1, 1999; 70(5): 832 - 838. [Abstract] [Full Text] [PDF]